Product correctly added to cart.

discount label
H-RIIPRHLQL-OH
View 3D

Biosynth logo

H-RIIPRHLQL-OH

Ref. 3D-PP46961

1mg
223.00 €
10mg
260.00 €
100mg
467.00 €
Estimated delivery in United States, on Tuesday 22 Apr 2025

Product Information

Name:
H-RIIPRHLQL-OH
Synonyms:
  • NH2-Arg-Ile-Ile-Pro-Arg-His-Leu-Gln-Leu-OH
Description:

Peptide H-RIIPRHLQL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RIIPRHLQL-OH include the following: beta2-Microglobulin required for cell surface expression of blastocyst MHC T Tanaka, T Ebata, A Tajima, K Kinoshita - Biochemical and , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X05005966 Structural modeling and molecular dynamics of the immune checkpoint molecule HLA-G T Arns , DA Antunes , JR Abella , MM Rigo - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.575076/full The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4 S Moradi , R Berry, P Pymm , C Hitchen - Journal of Biological , 2015 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)42690-0/abstract HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor S Liang, B Baibakov, A Horuzsko - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200209)32:9%3C2418::AID-IMMU2418%3E3.0.CO;2-L Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex Q Wang , H Song, H Cheng, J Qi, G Nam - Cellular & Molecular , 2020 - nature.comhttps://www.nature.com/articles/s41423-019-0258-5 The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide NG Walpole, L Kjer-Nielsen, L Kostenko - Journal of molecular , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283610001075 Rapid screening by cell-based fusion assay for identifying novel antivirals of glycoprotein b-mediated herpes simplex virus type 1 infection N Maeda, A Furukawa, K Kakita, M Anada - Biological and , 2016 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/bpb/39/11/39_b16-00533/_article/-char/ja/ Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2) M Shiroishi, K Maenaka - Protein and Peptide Letters, 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ppl/2009/00000016/00000004/art00017 Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) M Shiroishi, K Kuroki, L Rasubala - Proceedings of the , 2006 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0605228103 LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence M Ryu, Y Chen, J Qi, J Liu , Z Fan, G Nam, Y Shi - PloS one, 2011 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0019245 Nonclassical HLA-G molecules are classical peptide presenters M Diehl, C Munz , W Keilholz, S Stevanovic, N Holmes - Current Biology, 1996 - cell.comhttps://www.cell.com/current-biology/pdf/S0960-9822(02)00481-5.pdf Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy K Kuroki, S Kobayashi, M Shiroishi, M Kajikawa - Journal of , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175906003462 The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis K Kuroki, K Hirose, Y Okabe, Y Fukunaga - Human immunology, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S019888591200688X Structural and functional basis for LILRB immune checkpoint receptor recognition of HLA-G isoforms K Kuroki, H Matsubara, R Kanda - The Journal of , 2019 - journals.aai.orghttps://journals.aai.org/jimmunol/article/203/12/3386/109959 A soluble recombinant form of human leucocyte antigen-G 6 (srHLA-G6) FP Pela, JK Rustiguel, LC Rodrigues - Biochemical and , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X17306289 Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells DSJ Allan, M Colonna , LL Lanier - The Journal of , 1999 - rupress.orghttps://rupress.org/jem/article-abstract/189/7/1149/7946 Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface CS Clements, L Kjer-Nielsen - Proceedings of the , 2005 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0409676102 The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt CS Clements, L Kjer-Nielsen, L Kostenko - Section F: Structural , 2006 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?bw5122 Structural studies on HLA-G: implications for ligand and receptor binding CS Clements, L Kjer-Nielsen, J McCluskey - Human immunology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885906005209 Computational and atomistic studies applied to the understanding of the structural and behavioral features of the immune checkpoint HLA-G molecule and gene CC Alves, T Arns , ML Oliveira, P Moreau, DA Antunes - Human Immunology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885923000046 Peptide presentation and NK inhibition by HLA-G C Munz , S Stevanovic, HG Rammensee - Journal of reproductive , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165037899000297 The role of peptide presentation in the physiological function of HLA-G C Munz , P Nickolaus, E Lammert , S Pascolo - seminars in CANCER , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1044579X98901055 Evaluation of the reactivity and receptor competition of HLA-G isoforms toward available antibodies: implications of structural characteristics of HLA-G isoforms A Furukawa, M Meguro, R Yamazaki - International journal of , 2019 - mdpi.comhttps://www.mdpi.com/1422-0067/20/23/5947 The basis of HLA-G mediated dysregulation of immune effector cells A Celik - 2018 - scholar.archive.orghttps://scholar.archive.org/work/if73gcp2mvcxflnffakxef3wxi/access/wayback/https://mhh-publikationsserver.gbv.de/servlets/MCRFileNodeServlet/mhh_derivate_00000134/diss-celik_a.pdf

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-PP46961 H-RIIPRHLQL-OH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

  • Pick phone's country code.
  • Spain (España)+34
  • Portugal+351
  • Germany (Deutschland)+49
  • France+33
  • Italy (Italia)+39
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1
  • Andorra+376
  • Angola+244
  • Anguilla+1
  • Antigua and Barbuda+1
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1
  • Guadeloupe+590
  • Guam+1
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1
  • Saint Lucia+1
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1
  • Tuvalu+688
  • U.S. Virgin Islands+1
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
  • Pick phone's country code.
* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".